Intracellular α2C-Adrenoceptors: Storage depot, stunted development or signaling domain?

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 8, 2011, Pages 1495-1503

  Chotani, Maqsood A ^a,b   Flavahan, Nicholas A ^c  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cold; Endoplasmic Reticulum; Golgi; Signal transduction

Indexed keywords

ALPHA 2C ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR;

ARTICLE; CELL ORGANELLE; CELLULAR DISTRIBUTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; HUMANS; INTRACELLULAR SPACE; MODELS, BIOLOGICAL; ORGANELLES; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ADRENERGIC, ALPHA-2; SIGNAL TRANSDUCTION;

EID: 79959358168     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.05.006     Document Type: Review

References (105)

1. Regan J.W., Kobilka T.S., Yang-Feng T.L., Caron M.G., Lefkowitz R.J., Kobilka B.K. Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype. Proc Natl Acad Sci U S A 1988, 85:6301-6305.
2. Schaak S., Devedjian J.C., Cayla C., Sender Y., Paris H. Molecular cloning, sequencing and functional study of the promoter region of the human alpha2C4-adrenergic receptor gene. Biochem J 1997, 328(Pt 2):431-438.
3. Bond RA B.D., Eikenburg D.C., Hieble J.P., Hills R., Minneman K.P., Parra S. "Adrenoceptors: α2C-adrenoceptor.", IUPHAR database (IUPHAR-DB) Last modified on 2010-06-28. http://www.iuphar-db.org/DATABASE/ObjectDisplayForwardαobjectId=27.
4. Small K.M., Schwarb M.R., Glinka C., Theiss C.T., Brown K.M., Seman C.A., Liggett S.B. Alpha2A- and alpha2C-adrenergic receptors form homo- and heterodimers: the heterodimeric state impairs agonist-promoted GRK phosphorylation and beta-arrestin recruitment. Biochemistry 2006, 45:4760-4767.
5. Hein L., Altman J.D., Kobilka B.K. Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature 1999, 402:181-184.
6. Brede M., Wiesmann F., Jahns R., Hadamek K., Arnolt C., Neubauer S., Lohse M.J., Hein L. Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure. Circulation 2002, 106:2491-2496.
7. Small K.M., Forbes S.L., Rahman F.F., Bridges K.M., Liggett S.B. A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors. J Biol Chem 2000, 275:23059-23064.
8. Small K.M., Wagoner L.E., Levin A.M., Kardia S.L., Liggett S.B. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 2002, 347:1135-1142.
9. Small K.M., Mialet-Perez J., Seman C.A., Theiss C.T., Brown K.M., Liggett S.B. Polymorphisms of cardiac presynaptic alpha2C adrenergic receptors: diverse intragenic variability with haplotype-specific functional effects. Proc Natl Acad Sci U S A 2004, 101:13020-13025.
10. Scheinin M., Sallinen J., Haapalinna A. Evaluation of the alpha2C-adrenoceptor as a neuropsychiatric drug target studies in transgenic mouse models. Life Sci 2001, 68:2277-2285.
11. Lakhlani P.P., MacMillan L.B., Guo T.Z., McCool B.A., Lovinger D.M., Maze M., Limbird L.E. Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci U S A 1997, 94:9950-9955.
12. Altman J.D., Trendelenburg A.U., MacMillan L., Bernstein D., Limbird L., Starke K., Kobilka B.K., Hein L. Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. Mol Pharmacol 1999, 56:154-161.
13. Guimaraes S., Moura D. Vascular adrenoceptors: an update. Pharmacol Rev 2001, 53:319-356.
14. Flavahan N.A., Lindblad L.E., Verbeuren T.J., Shepherd J.T., Vanhoutte P.M. Cooling and alpha 1- and alpha 2-adrenergic responses in cutaneous veins: role of receptor reserve. Am J Physiol 1985, 249:H950-H955.
15. Shepard J., Vanhoutte P. The human cardiovascular system: facts and concepts 1979, Raven Press, New York.
16. Chotani M.A., Mitra S., Su B.Y., Flavahan S., Eid A.H., Clark K.R., Montague C.R., Paris H., Handy D.E., Flavahan N.A. Regulation of alpha(2)-adrenoceptors in human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2004, 286:H59-H67.
17. MacDonald E., Kobilka B.K., Scheinin M. Gene targeting-homing in on alpha 2-adrenoceptor-subtype function. Trends Pharmacol Sci 1997, 18:211-219.
18. Link R.E., Desai K., Hein L., Stevens M.E., Chruscinski A., Bernstein D., Barsh G.S., Kobilka B.K. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 1996, 273:803-805.
19. MacMillan L.B., Hein L., Smith M.S., Piascik M.T., Limbird L.E. Central hypotensive effects of the alpha2a-adrenergic receptor subtype. Science 1996, 273:801-803.
20. Chotani M.A., Flavahan S., Mitra S., Daunt D., Flavahan N.A. Silent alpha(2C)-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries. Am J Physiol Heart Circ Physiol 2000, 278:H1075-H1083.
21. Vanhoutte P. Physical factors of regulation. Handbook of Physiology, Section 2: The Cardiovascular System 1980, vol. II:443-474. Vascular Smooth Muscle American Physiological Society, Bethesda, MD. S.A. Bohr DF, H.V. Sparks (Eds.).
22. Honda M., Suzuki M., Nakayama K., Ishikawa T. Role of alpha2C-adrenoceptors in the reduction of skin blood flow induced by local cooling in mice. Br J Pharmacol 2007, 152:91-100.
23. Thompson-Torgerson C.S., Holowatz L.A., Flavahan N.A., Kenney W.L. Cold-induced cutaneous vasoconstriction is mediated by Rho kinase in vivo in human skin. Am J Physiol Heart Circ Physiol 2007, 292:H1700-H1705.
24. Chotani M.A., Mitra S., Eid A.H., Han S.A., Flavahan N.A. Distinct cAMP signaling pathways differentially regulate alpha2C-adrenoceptor expression: role in serum induction in human arteriolar smooth muscle cells. Am J Physiol Heart Circ Physiol 2005, 288:H69-H76.
25. Eid A.H., Chotani M.A., Mitra S., Miller T.J., Flavahan N.A. Cyclic AMP acts through Rap1 and JNK signaling to increase expression of cutaneous smooth muscle alpha2C-adrenoceptors. Am J Physiol Heart Circ Physiol 2008, 295:H266-H272.
26. Flavahan N.A., Flavahan S., Mitra S., Chotani M.A. The vasculopathy of Raynaud's phenomenon and scleroderma. Rheum Dis Clin North Am 2003, 29:275-291. vi.
27. Rosin D.L., Talley E.M., Lee A., Stornetta R.L., Gaylinn B.D., Guyenet P.G., Lynch K.R. Distribution of alpha 2C-adrenergic receptor-like immunoreactivity in the rat central nervous system. J Comp Neurol 1996, 372:135-165.
28. Brum P.C., Hurt C.M., Shcherbakova O.G., Kobilka B., Angelotti T. Differential targeting and function of alpha2A and alpha2C adrenergic receptor subtypes in cultured sympathetic neurons. Neuropharmacology 2006, 51:397-413.
29. Richman J.G., Regan J.W. Alpha 2-adrenergic receptors increase cell migration and decrease F-actin labeling in rat aortic smooth muscle cells. Am J Physiol 1998, 274:C654-C662.
30. Angelotti T., Daunt D., Shcherbakova O.G., Kobilka B., Hurt C.M. Regulation of G-protein coupled receptor traffic by an evolutionary conserved hydrophobic signal. Traffic 2010, 11:560-578.
31. Daunt D.A., Hurt C., Hein L., Kallio J., Feng F., Kobilka B.K. Subtype-specific intracellular trafficking of alpha2-adrenergic receptors. Mol Pharmacol 1997, 51:711-720.
32. Filipeanu C.M., de Vries R., Danser A.H., Kapusta D.R. Modulation of alpha(2C) adrenergic receptor temperature-sensitive trafficking by HSP90. Biochim Biophys Acta 2011, 1813:346-357.
33. Hurt C.M., Feng F.Y., Kobilka B. Cell-type specific targeting of the alpha 2c-adrenoceptor. Evidence for the organization of receptor microdomains during neuronal differentiation of PC12 cells. J Biol Chem 2000, 275:35424-35431.
34. Prinster S.C., Holmqvist T.G., Hall R.A. Alpha2C-adrenergic receptors exhibit enhanced surface expression and signaling upon association with beta2-adrenergic receptors. J Pharmacol Exp Ther 2006, 318:974-981.
35. Wozniak M., Limbird L.E. The three alpha 2-adrenergic receptor subtypes achieve basolateral localization in Madin-Darby canine kidney II cells via different targeting mechanisms. J Biol Chem 1996, 271:5017-5024.
36. Kurose H., Lefkowitz R.J. Differential desensitization and phosphorylation of three cloned and transfected alpha 2-adrenergic receptor subtypes. J Biol Chem 1994, 269:10093-10099.
37. Velasco A., Hendricks L., Moremen K.W., Tulsiani D.R., Touster O., Farquhar M.G. Cell type-dependent variations in the subcellular distribution of alpha-mannosidase I and II. J Cell Biol 1993, 122:39-51.
38. Herscovics A. Importance of glycosidases in mammalian glycoprotein biosynthesis. Biochim Biophys Acta 1999, 1473:96-107.
39. Jeyaraj S.C., Chotani M.A., Mitra S., Gregg H.E., Flavahan N.A., Morrison K.J. Cooling evokes redistribution of alpha2C-adrenoceptors from Golgi to plasma membrane in transfected human embryonic kidney 293 cells. Mol Pharmacol 2001, 60:1195-1200.
40. Brown C.R., Hong-Brown L.Q., Biwersi J., Verkman A.S., Welch W.J. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones 1996, 1:117-125.
41. Wang X., Koulov A.V., Kellner W.A., Riordan J.R., Balch W.E. Chemical and biological folding contribute to temperature-sensitive DeltaF508 CFTR trafficking. Traffic 2008, 9:1878-1893.
42. Robben J.H., Deen P.M. Pharmacological chaperones in nephrogenic diabetes insipidus: possibilities for clinical application. BioDrugs 2007, 21:157-166.
43. Robben J.H., Kortenoeven M.L., Sze M., Yae C., Milligan G., Oorschot V.M., Klumperman J., Knoers N.V., Deen P.M. Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists. Proc Natl Acad Sci U S A 2009, 106:12195-12200.
44. Zhou F., Filipeanu C.M., Duvernay M.T., Wu G. Cell-surface targeting of alpha2-adrenergic receptors - inhibition by a transport deficient mutant through dimerization. Cell Signal 2006, 18:318-327.
45. Filipeanu C.M. Temperature-dependent interactions of alpha2C-adrenergic receptor with molecular chaperones. Circulation 2008, 118:s514.
46. Lee A., Talley E., Rosin D.L., Lynch K.R. Characterization of alpha 2A-adrenergic receptors in GT1 neurosecretory cells. Neuroendocrinology 1995, 62:215-225.
47. Ma D., Jan L.Y. ER transport signals and trafficking of potassium channels and receptors. Curr Opin Neurobiol 2002, 12:287-292.
48. Schwappach B., Zerangue N., Jan Y.N., Jan L.Y. Molecular basis for K(ATP) assembly: transmembrane interactions mediate association of a K+channel with an ABC transporter. Neuron 2000, 26:155-167.
49. Vivithanaporn P., Yan S., Swanson G.T. Intracellular trafficking of KA2 kainate receptors mediated by interactions with coatomer protein complex I (COPI) and 14-3-3 chaperone systems. J Biol Chem 2006, 281:15475-15484.
50. O'Kelly I., Butler M.H., Zilberberg N., Goldstein S.A. Forward transport. 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals. Cell 2002, 111:577-588.
51. Olli-Lahdesmaki T., Kallio J., Scheinin M. Receptor subtype-induced targeting and subtype-specific internalization of human alpha(2)-adrenoceptors in PC12 cells. J Neurosci 1999, 19:9281-9288.
52. Teasdale R.D., Matheson F., Gleeson P.A. Post-translational modifications distinguish cell surface from Golgi-retained beta 1,4 galactosyltransferase molecules, Golgi localization involves active retention. Glycobiology 1994, 4:917-928.
53. Wu J., Chalupny N.J., Manley T.J., Riddell S.R., Cosman D., Spies T. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein. J Immunol 2003, 170:4196-4200.
54. Eng F.J., Varlamov O., Fricker L.D. Sequences within the cytoplasmic domain of gp180/carboxypeptidase D mediate localization to the trans-Golgi network. Mol Biol Cell 1999, 10:35-46.
55. Wahlberg J.M., Geffen I., Reymond F., Simmen T., Spiess M. Trans-Golgi retention of a plasma membrane protein: mutations in the cytoplasmic domain of the asialoglycoprotein receptor subunit H1 result in trans-Golgi retention. J Cell Biol 1995, 130:285-297.
56. Aoki D., Lee N., Yamaguchi N., Dubois C., Fukuda M.N. Golgi retention of a trans-Golgi membrane protein, galactosyltransferase, requires cysteine and histidine residues within the membrane-anchoring domain. Proc Natl Acad Sci U S A 1992, 89:4319-4323.
57. Wang Z.H., Gershon M.D., Lungu O., Zhu Z., Gershon A.A. Trafficking of varicella-zoster virus glycoprotein gI: T(338)-dependent retention in the trans-Golgi network, secretion, and mannose 6-phosphate-inhibitable uptake of the ectodomain. J Virol 2000, 74:6600-6613.
58. Braiterman L., Nyasae L., Guo Y., Bustos R., Lutsenko S., Hubbard A. Apical targeting and Golgi retention signals reside within a 9-amino acid sequence in the copper-ATPase, ATP7B. Am J Physiol Gastrointest Liver Physiol 2009, 296:G433-G444.
59. Bailey S.R., Mitra S., Flavahan S., Flavahan N.A. Reactive oxygen species from smooth muscle mitochondria initiate cold-induced constriction of cutaneous arteries. Am J Physiol Heart Circ Physiol 2005, 289:H243-H250.
60. Bailey S.R., Eid A.H., Mitra S., Flavahan S., Flavahan N.A. Rho kinase mediates cold-induced constriction of cutaneous arteries: role of alpha2C-adrenoceptor translocation. Circ Res 2004, 94:1367-1374.
61. Hein L., Ishii K., Coughlin S.R., Kobilka B.K. Intracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor. J Biol Chem 1994, 269:27719-27726.
62. Seksek O., Biwersi J., Verkman A.S. Direct measurement of trans-Golgi pH in living cells and regulation by second messengers. J Biol Chem 1995, 270:4967-4970.
63. Pap E.H., Dansen T.B., van Summeren R., Wirtz K.W. Peptide-based targeting of fluorophores to organelles in living cells. Exp Cell Res 2001, 265:288-293.
64. Roseberry A.G., Bunemann M., Elavunkal J., Hosey M.M. Agonist-dependent delivery of M(2) muscarinic acetylcholine receptors to the cell surface after pertussis toxin treatment. Mol Pharmacol 2001, 59:1256-1268.
65. Mittar S., Ulyatt C., Howell G.J., Bruns A.F., Zachary I., Walker J.H., Ponnambalam S. VEGFR1 receptor tyrosine kinase localization to the Golgi apparatus is calcium-dependent. Exp Cell Res 2009, 315:877-889.
66. Kim K.A., von Zastrow M. Neurotrophin-regulated sorting of opioid receptors in the biosynthetic pathway of neurosecretory cells. J Neurosci 2003, 23:2075-2085.
67. N.J. Freedman, R.J. Lefkowitz, Desensitization of G protein-coupled receptors, Recent Prog Horm Res 51 (1996) 319-351; discussion 352-313.
68. Flavahan N.A. The role of alpha2-adrenoceptors as cutaneous thermosensors. News in Physiological Sciences 1991, 6:251-255.
69. Guimaraes S., Moura D. Vascular adrenoceptors: an update. Pharmacol Rev 2001, 53:319-356.
70. Wigley F.M., Flavahan N.A. Raynaud's phenomenon. Rheum Dis Clin North Am 1996, 22:765-781.
71. Ekenvall L., Lindblad L.E., Norbeck O., Etzell B.M. Alpha-Adrenoceptors and cold-induced vasoconstriction in human finger skin. Am J Physiol 1988, 255:H1000-H1003.
72. Faber J.E. Effect of local tissue cooling on microvascular smooth muscle and postjunctional alpha 2-adrenoceptors. Am J Physiol 1988, 255:H121-H130.
73. Harker C.T., Ousley P.J., Bowman C.J., Porter J.M. Cooling augments alpha 2-adrenoceptor-mediated contractions in rat tail artery. Am J Physiol 1991, 260:H1166-H1171.
74. Harker C.T., Ousley P.J., Harris E.J., Edwards J.M., Taylor L.M., Porter J.M. The effects of cooling on human saphenous vein reactivity to adrenergic agonists. J Vasc Surg 1990, 12:45-49.
75. Freedman R.R., Baer R.P., Mayes M.D. Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1- adrenergic antagonists in idiopathic Raynaud's disease. Circulation 1995, 92:1448-1451.
76. Lindblad L.E., Ekenvall L. Alpha 2-adrenoceptor inhibition in patients with vibration white fingers. Kurume Med J 1990, 37(Suppl):S95-S99.
77. Flavahan N.A. Phenylpropanolamine constricts mouse and human blood vessels by preferentially activating alpha2-adrenoceptors. J Pharmacol Exp Ther 2005, 313:432-439.
78. Flavahan N.A., Rimele T.J., Cooke J.P., Vanhoutte P.M. Characterization of postjunctional alpha-1 and alpha-2 adrenoceptors activated by exogenous or nerve-released norepinephrine in the canine saphenous vein. J Pharmacol Exp Ther 1984, 230:699-705.
79. Flavahan N.A., Vanhoutte P.M. Alpha-1 and alpha-2 adrenoceptor: response coupling in canine saphenous and femoral veins. J Pharmacol Exp Ther 1986, 238:131-138.
80. Dunn W.R., McGrath J.C., Wilson V.G. Influence of angiotensin II on the alpha-adrenoceptors involved in mediating the response to sympathetic nerve stimulation in the rabbit isolated distal saphenous artery. Br J Pharmacol 1991, 102:10-12.
81. Templeton A.G., Macmillan J., McGrath J.C., Storey N.D., Wilson V.G. Evidence for prazosin-resistant, rauwolscine-sensitive alpha-adrenoceptors mediating contractions in the isolated vascular bed of the rat tail. Br J Pharmacol 1989, 97:563-571.
82. Xiao X.H., Rand M.J. Vasoconstrictor responses to the alpha 2-adrenoceptor agonist UK14304 during responses to noradrenaline, phenylephrine, serotonin and vasopressin of the rat tail artery. Arch Int Pharmacodyn Ther 1990, 308:63-75.
83. Jantschak F., Popp A.M., Hofmann R.A., Villalon C.M., Centurion D., Pertz H.H. Postjunctional alpha2C-adrenoceptors mediate vasoconstriction in rat tail artery: influence of precontraction and temperature on vasoreactivity. Naunyn Schmiedebergs Arch Pharmacol 2010, 382:487-497.
84. Hughes J.M., Wirth O., Krajnak K., Miller R., Flavahan S., Berkowitz D.E., Welcome D., Flavahan N.A. Increased oxidant activity mediates vascular dysfunction in vibration injury. J Pharmacol Exp Ther 2009, 328:223-230.
85. Denning G.M., Anderson M.P., Amara J.F., Marshall J., Smith A.E., Welsh M.J. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 1992, 358:761-764.
86. Delaunay J.L., Durand-Schneider A.M., Delautier D., Rada A., Gautherot J., Jacquemin E., Ait-Slimane T., Maurice M. A missense mutation in ABCB4 gene involved in progressive familial intrahepatic cholestasis type 3 leads to a folding defect that can be rescued by low temperature. Hepatology 2009, 49:1218-1227.
87. Hague C., Lee S.E., Chen Z., Prinster S.C., Hall R.A., Minneman K.P. Heterodimers of alpha1B- and alpha1D-adrenergic receptors form a single functional entity. Mol Pharmacol 2006, 69:45-55.
88. Prinster S.C., Hague C., Hall R.A. Heterodimerization of g protein-coupled receptors: specificity and functional significance. Pharmacol Rev 2005, 57:289-298.
89. Uberti M.A., Hague C., Oller H., Minneman K.P., Hall R.A. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors. J Pharmacol Exp Ther 2005, 313:16-23.
90. Wang X., Venable J., LaPointe P., Hutt D.M., Koulov A.V., Coppinger J., Gurkan C., Kellner W., Matteson J., Plutner H., Riordan J.R., Kelly J.W., Yates J.R., Balch W.E. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 2006, 127:803-815.
91. Sun F., Mi Z., Condliffe S.B., Bertrand C.A., Gong X., Lu X., Zhang R., Latoche J.D., Pilewski J.M., Robbins P.D., Frizzell R.A. Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia. FASEB J 2008, 22:3255-3263.
92. Kanagy N.L. Increased vascular responsiveness to alpha 2-adrenergic stimulation during NOS inhibition-induced hypertension. Am J Physiol 1997, 273:H2756-H2764.
93. Tan C.M., Brady A.E., Nickols H.H., Wang Q., Limbird L.E. Membrane trafficking of G protein-coupled receptors. Annu Rev Pharmacol Toxicol 2004, 44:559-609.
94. Calebiro D., Nikolaev V.O., Persani L., Lohse M.J. Signaling by internalized G-protein-coupled receptors. Trends Pharmacol Sci 2010, 31:221-228.
95. Zweifel L.S., Kuruvilla R., Ginty D.D. Functions and mechanisms of retrograde neurotrophin signalling. Nat Rev Neurosci 2005, 6:615-625.
96. Gobeil F., Fortier A., Zhu T., Bossolasco M., Leduc M., Grandbois M., Heveker N., Bkaily G., Chemtob S., Barbaz D. G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm. Can J Physiol Pharmacol 2006, 84:287-297.
97. Valdehita A., Bajo A.M., Fernandez-Martinez A.B., Arenas M.I., Vacas E., Valenzuela P., Ruiz-Villaespesa A., Prieto J.C., Carmena M.J. Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer. Peptides 2010, 31:2035-2045.
98. Escola J.M., Kuenzi G., Gaertner H., Foti M., Hartley O. CC chemokine receptor 5 (CCR5) desensitization: cycling receptors accumulate in the trans-Golgi network. J Biol Chem 2010, 285:41772-41780.
99. Lelouvier B., Tamagno G., Kaindl A.M., Roland A., Lelievre V., Le Verche V., Loudes C., Gressens P., Faivre-Baumann A., Lenkei Z., Dournaud P. Dynamics of somatostatin type 2A receptor cargoes in living hippocampal neurons. J Neurosci 2008, 28:4336-4349.
100. Jewell-Motz E.A., Liggett S.B. G protein-coupled receptor kinase specificity for phosphorylation and desensitization of alpha2-adrenergic receptor subtypes. J Biol Chem 1996, 271:18082-18087.
101. Eason M.G., Liggett S.B. Functional alpha 2-adrenergic receptor-Gs coupling undergoes agonist-promoted desensitization in a subtype-selective manner. Biochem Biophys Res Commun 1993, 193:318-323.
102. Eason M.G., Liggett S.B. Subtype-selective desensitization of alpha 2-adrenergic receptors. Different mechanisms control short and long term agonist-promoted desensitization of alpha 2C10, alpha 2C4, and alpha 2C2. J Biol Chem 1992, 267:25473-25479.
103. Dupre D.J., Baragli A., Rebois R.V., Ethier N., Hebert T.E. Signalling complexes associated with adenylyl cyclase II are assembled during their biosynthesis. Cell Signal 2007, 19:481-489.
104. Dupre D.J., Robitaille M., Ethier N., Villeneuve L.R., Mamarbachi A.M., Hebert T.E. Seven transmembrane receptor core signaling complexes are assembled prior to plasma membrane trafficking. J Biol Chem 2006, 281:34561-34573.
105. Joshi M.S., Ferguson T.B., Johnson F.K., Johnson R.A., Parthasarathy S., Lancaster J.R. Receptor-mediated activation of nitric oxide synthesis by arginine in endothelial cells. Proc Natl Acad Sci U S A 2007, 104:9982-9987.